Clinical Trials Logo

Thymoma Type B2 clinical trials

View clinical trials related to Thymoma Type B2.

Filter by:
  • None
  • Page 1

NCT ID: NCT02307500 Completed - Ovarian Cancer Clinical Trials

Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy

RESOUND
Start date: December 2014
Phase: Phase 2
Study type: Interventional

This is a single arm, single-stage, phase II trial to evaluate the activity of Regorafenib in patients with metastatic solid tumors (pancreatic cancer, ovarian cancer, melanoma, sarcoma, thymoma (type B2 - B3) and thymic carcinoma, who have progressed after standard therapy.